Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICAT in Resectable Stage N2-3A/3B NSCLC
jRCT1051180028Completed
- Sponsor
- The Uehara Memorial Foundation
- Start
- Mar 2019
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of carboplatin and paclitaxel in non-small cell lung cancer (NSCLC), sponsored by The Uehara Memorial Foundation. Primary endpoint: Treatment completion. Started Mar 2019; status: completed.
02
Drugs
carboplatinpaclitaxel
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on jRCT1051180028.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1051180028.